Clinical Trial Update: A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV [Phase 2]

View source ↗

Summary

A Phase 2 study to evaluate resmetirom in participants with MASLD and HIV; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• Resmetirom (resmetirom)

Snippet

Sponsor: Naga P. Chalasani | Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, HIV (Human Immunodeficiency Virus) | Phase 2 | Status: NOT_YET_RECRUITING